drugset / Trial / NCT05449704
Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in Healthy Adult Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
Pharmacokinetics and safety Profiles after administration of DA-5218 and co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in healthy adult volunteers
Timeline
- Start
- 2022-07-08
- Primary completion
- 2022-09-03
- Completion
- 2022-09-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-5218 | Unknown | — | — |
| Subject | DA-5218-R1 | Unknown | — | — |
| Subject | DA-5218-R2 | Unknown | — | — |
| Subject | DA-5218-R3 | Unknown | — | — |
Indications
No indication recorded.